We are live on ! Find out more
PGM

Parian Global Management Portfolio holdings

AUM $30.8M
1-Year Est. Return 51.25%
This Fund
S&P 500
This Quarter Est. Return
-33.3%
1 Year Est. Return
-51.25%
3 Year Est. Return
+65.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$48.5M
AUM Growth
-$76M
Cap. Flow
-$46.6M
Cap. Flow %
-96.06%
Top 10 Hldgs %
96.25%
Holding
34
New
1
Increased
3
Reduced
8
Closed
22

Top Buys

Rank Stock Value
1
SERA icon
Sera Prognostics
SERA
+$3.4M
2
CVRX icon
CVRx
CVRX
+$1.22M
3
STXS icon
Stereotaxis
STXS
+$584K
4
ADMA icon
ADMA Biologics
ADMA
+$491K

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$5.98M
2
QTRX icon
Quanterix
QTRX
+$2.76M
3
SGRY icon
Surgery Partners
SGRY
+$2.45M
4
USIO icon
Usio Inc
USIO
+$2.4M
5
ANGO icon
AngioDynamics
ANGO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAPO
1
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$18.5M 38.04%
166,014
-5,385
-3% -$673K
APEN
2
DELISTED
Apollo Endosurgery, Inc.
APEN
$4.47M 9.21%
739,165
-252,064
-25% -$1.54M
SERA icon
3
Sera Prognostics
SERA
$85M
$3.52M 7.25%
929,073
+586,205
+171% +$3.4M
CVRX icon
4
CVRx
CVRX
$130M
$3.24M 6.67%
540,273
+150,737
+39% +$1.22M
RNLX
5
DELISTED
Renalytix plc American Depositary Shares
RNLX
$3.18M 6.55%
459,461
-115,245
-20% -$1.22M
TOI icon
6
The Oncology Institute
TOI
$507M
$3.17M 6.53%
444,244
-22,432
-5% -$151K
STIM icon
7
Neuronetics
STIM
$131M
$2.9M 5.97%
955,999
-463,700
-33% -$1.57M
CELL
8
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.84M 5.85%
399,402
-2,085
-0.5% -$17.2K
ATEC icon
9
Alphatec Holdings
ATEC
$1.26B
$2.68M 5.52%
232,864
-148,804
-39% -$1.61M
STXS icon
10
Stereotaxis
STXS
$140M
$2.27M 4.67%
607,269
+123,750
+26% +$584K
IRTC icon
11
iRhythm Holdings
IRTC
$3.54B
$1.24M 2.56%
7,898
-46,568
-85% -$5.98M
ADMA icon
12
ADMA Biologics
ADMA
$1.94B
$576K 1.19%
+315,000
New +$491K
ANGO icon
13
AngioDynamics
ANGO
$556M
– –
-82,500
Closed -$2.27M
AZTA icon
14
Azenta
AZTA
$1.3B
– –
-20,500
Closed -$2.11M
BDSX icon
15
Biodesix
BDSX
$231M
– –
-19,811
Closed -$2.1M
BLFS icon
16
BioLife Solutions
BLFS
$1.5B
– –
-55,100
Closed -$2.05M
CSTL icon
17
Castle Biosciences
CSTL
$773M
– –
-29,498
Closed -$1.26M
IRTC icon
18
CALL
iRhythm Holdings
IRTC
$3.54B
– –
-23,900
Closed -$2.81M
PFE icon
19
PUT
Pfizer
PFE
$143B
– –
-100,000
Closed -$5.91M
PODD icon
20
Insulet
PODD
$11B
– –
-6,300
Closed -$1.68M
QDEL icon
21
QuidelOrtho
QDEL
$1.13B
– –
-6,000
Closed -$810K
QTRX icon
22
Quanterix
QTRX
$185M
– –
-65,010
Closed -$2.76M
SGRY icon
23
Surgery Partners
SGRY
$1.99B
– –
-45,797
Closed -$2.45M
STIM icon
24
CALL
Neuronetics
STIM
$131M
– –
-200,000
Closed -$892K
TKNO icon
25
Alpha Teknova
TKNO
$279M
– –
-38,069
Closed -$780K
1
2

Similar funds

VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
KL
Kokino LLC Stamford, Connecticut $28M AUM 16.9% 1-Year Est. Return

Parian Global Management's Q1 2022 Portfolio in Review

As of Q1 2022, Parian Global Management held 34 positions worth $48.5M, down 61% from $125M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Parian Global Management withdrew a net $46.6M in Q1 2022, closing 22 positions and reducing 8 holdings. Its most notable exit was Quanterix, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 87% a quarter earlier, followed by Technology.

Against the trend, Parian Global Management opened a new position in ADMA Biologics worth $576K.

  • Parian Global Management's largest Q1 2022 buy was ADMA Biologics: 315,000 shares worth $576K.
  • Parian Global Management added most to Sera Prognostics in Q1 2022, an estimated $3.4M increase.
  • Parian Global Management's biggest Q1 2022 reduction was iRhythm Holdings, cutting an estimated $5.98M.
  • Parian Global Management fully exited Quanterix in Q1 2022, selling an estimated $2.76M.
  • Parian Global Management's ten largest holdings make up 96% of its $48.5M portfolio in Q1 2022.
  • Parian Global Management opened 1 new position and closed 22 in Q1 2022.
  • Parian Global Management's portfolio value fell 61% quarter-over-quarter to $48.5M.

Based on Parian Global Management's 13F filing for Q1 2022, filed 16 May 2022.